ORIC Pharmaceuticals, Inc. (ORIC) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

ORIC Pharmaceuticals, Inc. (ORIC) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

ORIC Cash Flow Statement

ORIC Pharmaceuticals, Inc. (ORIC) cash flow statement — 9-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	-31.61M	-32.44M	-22.48M	-25.11M	-30.84M	-32.77M	-28.05M	-28.8M	-25.63M	-30.35M	-24.27M	-19.64M	-21.14M	-20.63M	-15.33M	-19.32M	-17.78M	-22.72M	-16.28M	-12.14M
Operating CF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	-2.47%	1.03%	19.86%	12.8%	-20.36%	-7.98%	-15.59%	-46.59%	-21.19%	-47.15%	-58.33%	-1.68%	-18.95%	9.2%	5.86%	-59.12%	-7.39%	-52.46%	8.65%	-26.74%
Net Income	-41.49M	-35.77M	-30.5M	-32.59M	-36.35M	-30.02M	-36.31M	-34.57M	-31.96M	-25.01M	-28.33M	-25.48M	-22.94M	-23.95M	-20.85M	-24.83M	-20.29M	-23.16M	-22.77M	-18.43M
Depreciation & Amortization	264K	270K	320K	288K	310K	302K	304K	270K	272K	261K	263K	257K	259K	253K	247K	221K	247K	251K	229K	217K
Stock-Based Compensation	7.09M	6.9M	6.28M	5.63M	6.57M	0	5.2M	5.06M	5M	4.96M	3.92M	3.86M	3.83M	3.61M	3.13M	3.29M	4.09M	3.94M	3.5M	3.4M
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Cash Items	291K	162K	-240K	-587K	-591K	5.43M	-1.63M	-1.95M	-2.3M	-2.4M	-2.11M	-1.92M	-1.25M	-861K	-580K	-370K	-94K	42K	148K	330K
Working Capital Changes	2.24M	-4M	1.66M	2.14M	-780K	-8.49M	4.38M	2.39M	3.37M	-8.17M	1.98M	3.63M	-1.03M	311K	2.72M	2.37M	-1.73M	-3.8M	2.61M	2.34M
Change in Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	2.22M	0	-448K	0	0	-7.91M	3.03M	757K	3.8M	-5.76M	0	3.91M	0	-792K	0	500K	-158K	-3.26M	2.48M	1.64M
Cash from Investing	11.86M	-17.98M	16.98M	-110.53M	-76.93M	22.45M	42.66M	23.07M	18.28M	-61.87M	20.96M	-57.83M	-19.31M	12.78M	28.3M	-685K	-46.2M	-90.66M	351K	35.07M
Capital Expenditures	-356K	-2K	-450K	-35K	-63K	-387K	-219K	551K	-333K	-218K	-57K	-77K	-405K	-310K	-287K	-401K	-667K	-723K	-389K	-233K
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0	0	310K	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	223K	0	0	0	0	-969K	0	0	0	0	0	-310K	0	0	0	0	0	0
Cash from Financing	828K	61.14M	1.5M	109.45M	134.3M	253K	575K	126K	816K	125.2M	453K	31K	85.17M	0	24.79M	1K	415K	16K	813K	48.59M
Debt Issued (Net)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Equity Issued (Net)	828K	62.13M	1.5M	110.44M	133.93M	253K	575K	126K	816K	125M	226K	31K	85M	0	25M	1K	415K	16K	0	50M
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-1.25M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	0	-993K	0	-993K	377K	0	0	0	0	198K	227K	0	174K	0	-207K	0	0	0	813K	-1.41M
Net Change in Cash	-18.91M	10.73M	-4M	-26.2M	26.53M	-10.07M	15.18M	-5.6M	-6.53M	32.98M	-2.85M	-77.44M	44.72M	-7.85M	37.76M	-20M	-63.56M	-113.36M	-15.12M	71.52M
Free Cash Flow	-31.96M	-32.44M	-22.87M	-25.15M	-30.91M	-33.16M	-28.27M	-29.21M	-25.96M	-30.57M	-24.33M	-19.72M	-21.55M	-20.94M	-15.62M	-19.72M	-18.44M	-23.44M	-16.67M	-12.38M
FCF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FCF Growth %	-3.42%	2.18%	19.11%	13.92%	-19.06%	-8.47%	-16.22%	-48.13%	-20.45%	-46.01%	-55.78%	-0.01%	-16.85%	10.68%	6.34%	-59.36%	-10.52%	-55.41%	8.57%	-28.5%
FCF per Share	-0.30	-0.31	-0.26	-0.25	-0.40	-0.47	-0.40	-0.41	-0.37	-0.45	-0.42	-0.34	-0.47	-0.46	-0.39	-0.50	-0.47	-0.59	-0.42	-0.32
FCF Conversion (FCF/Net Income)	0.76x	0.91x	0.74x	0.77x	0.85x	1.09x	0.77x	0.83x	0.80x	1.21x	0.86x	0.77x	0.92x	0.86x	0.74x	0.78x	0.88x	0.98x	0.72x	0.66x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0